| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3850552 | American Journal of Kidney Diseases | 2008 | 5 Pages |
Abstract
The present study suggests that in the absence of a hematostatic disorder and/or uncontrolled hypertension, bleeding risk during kidney biopsy is not increased in patients with systemic amyloidosis. Kidney biopsy can be performed safely using the same screening criteria as for patients without amyloidosis.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Sandra M. MD, Fernando C. MD, PhD, Donna J. MD, Morie A. MD, Fernando G. MD, Nelson MD,